AMICUS THERAPEUTICS, INC. Accounts Payable
AMICUS THERAPEUTICS, INC. had Accounts Payable of $28.63 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-02-20
- 2025-12-31: Accounts Payable, Current $28.63M.
- 2025-09-30: Accounts Payable, Current $19.10M.
- 2025-06-30: Accounts Payable, Current $13.89M.
- 2025-03-31: Accounts Payable, Current $14.45M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-12-31 | $28.63M 10-K · filed 2026-02-20 |
| 2025-09-30 | $19.10M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $13.89M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $14.45M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $12.95M 10-K · filed 2026-02-20 |
| 2024-09-30 | $13.48M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $32.06M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $9.21M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $15.12M 10-K · filed 2025-02-19 |
| 2023-09-30 | $23.15M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $13.52M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $24.96M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $15.41M 10-K · filed 2024-02-28 |
| 2022-09-30 | $12.05M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $23.11M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $22.91M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $21.51M 10-K · filed 2023-03-01 |
| 2021-09-30 | $24.47M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $13.76M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $16.11M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $17.06M 10-K · filed 2022-02-24 |
| 2020-09-30 | $14.76M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $14.31M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $16.24M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $21.72M 10-K · filed 2021-03-01 |
| 2018-12-31 | $6.61M 10-K · filed 2020-03-02 |
| 2017-12-31 | $7.87M 10-K · filed 2019-02-28 |
| 2016-12-31 | $12.90M 10-K · filed 2018-03-01 |
| 2015-12-31 | $16.48M 10-K/A · filed 2017-03-03 |
| 2014-12-31 | $5.87M 10-K · filed 2016-02-29 |
| 2013-12-31 | $2.15M 10-K · filed 2015-03-03 |
| 2012-12-31 | $2.12M 10-K · filed 2014-03-03 |
| 2011-12-31 | $2.58M 10-K · filed 2013-03-13 |